143 related articles for article (PubMed ID: 31969028)
1. Molecular imaging-monitored radiofrequency hyperthermia-enhanced intratumoral herpes simplex virus-thymidine kinase gene therapy for rat orthotopic ovarian cancer.
Li Y; Zhao S; Zhang F; Jin G; Zhou Y; Li P; Shin D; Yang X
Int J Hyperthermia; 2020; 37(1):101-109. PubMed ID: 31969028
[No Abstract] [Full Text] [Related]
2. Non-Small-Cell Lung Cancer: Feasibility of Intratumoral Radiofrequency Hyperthermia-enhanced Herpes Simplex Virus Thymidine Kinase Gene Therapy.
Ji J; Weng Q; Zhang F; Xiong F; Jin Y; Hui J; Song J; Gao J; Chen M; Li Q; Shin D; Yang X
Radiology; 2018 Aug; 288(2):612-620. PubMed ID: 29893649
[TBL] [Abstract][Full Text] [Related]
3. Orthotopic hepatic cancer: radiofrequency hyperthermia-enhanced intratumoral herpes simplex virus-thymidine kinase gene therapy.
Xiong F; Zhang F; Jin Y; Weng Q; Song J; Zhou G; Shin D; Zheng C; Yang X
Oncotarget; 2018 Mar; 9(18):14099-14108. PubMed ID: 29581830
[TBL] [Abstract][Full Text] [Related]
4. Epithelial ovarian cancer: feasibility of image-guided intratumoral radiofrequency hyperthermia-enhanced direct gene therapy.
Jin G; Li Y; Zhang F; Li P; Zhao L; Zhou Y; Ji H; Pietrini S; Zhai B; Yang X
Am J Cancer Res; 2019; 9(2):378-389. PubMed ID: 30906635
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency hyperthermia-enhanced herpes simplex virus-thymidine kinase/ganciclovir direct intratumoral gene therapy of esophageal squamous cancers.
Shi Y; Wang J; Bai Z; Li Y; Qiu L; Zhai B; Zhang F; Yang X
Am J Cancer Res; 2016; 6(9):2054-2063. PubMed ID: 27725910
[TBL] [Abstract][Full Text] [Related]
6. Cholangiocarcinoma: molecular imaging-guided radiofrequency hyperthermia-enhanced intratumoral herpes simplex virus thymidine kinase gene therapy.
Jin Y; Gao J; Weng Q; Xiong F; Gu S; Shivaram G; Zhang F; Yang X
Am J Cancer Res; 2018; 8(3):502-513. PubMed ID: 29637004
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency hyperthermia-enhanced herpes simplex virus-thymidine kinase/ganciclovir direct intratumoral gene therapy of hepatocellular carcinoma.
Wang J; Shi Y; Bai Z; Li Y; Qiu L; Johnson G; Zhang F; Yang X
Int J Hyperthermia; 2017 Mar; 33(2):170-177. PubMed ID: 27569361
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency hyperthermia promotes the therapeutic effects on chemotherapeutic-resistant breast cancer when combined with heat shock protein promoter-controlled HSV-TK gene therapy: Toward imaging-guided interventional gene therapy.
Luo J; Wu X; Zhou F; Zhou Y; Huang T; Liu F; Han G; Chen L; Bai W; Wu X; Sun J; Yang X
Oncotarget; 2016 Oct; 7(40):65042-65051. PubMed ID: 27542255
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment of cholangiocarcinoma with interventional radiofrequency hyperthermia and heat shock protein promoter-mediated HSV-TK gene therapy.
Luo J; Zhou J; Xie F; Zhu Y; Zhou F; Zhang S; Jiang S; He J; Liu J; Wu X; Zhang Y; Sun J; Yang X
Am J Cancer Res; 2018; 8(8):1595-1603. PubMed ID: 30210927
[TBL] [Abstract][Full Text] [Related]
10. Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma.
Rainov NG; Fels C; Droege JW; Schäfer C; Kramm CM; Chou TC
Cancer Gene Ther; 2001 Sep; 8(9):662-8. PubMed ID: 11593335
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral radiofrequency hyperthermia-enhanced direct chemotherapy of pancreatic cancer.
Bai Z; Shi Y; Wang J; Qiu L; Monroe EJ; Teng G; Zhang F; Yang X
Oncotarget; 2017 Jan; 8(2):3591-3599. PubMed ID: 27690303
[TBL] [Abstract][Full Text] [Related]
12. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
13. Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan.
Wildner O; Blaese RM; Morris JC
Hum Gene Ther; 1999 Nov; 10(16):2679-87. PubMed ID: 10566896
[TBL] [Abstract][Full Text] [Related]
14. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV
Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410
[TBL] [Abstract][Full Text] [Related]
15. Combination of PEI-Mn0.5Zn0.5Fe2O4 nanoparticles and pHsp 70-HSV-TK/GCV with magnet-induced heating for treatment of hepatoma.
Tang Q; Lu M; Chen D; Liu P
Int J Nanomedicine; 2015; 10():7129-43. PubMed ID: 26604760
[TBL] [Abstract][Full Text] [Related]
16. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR
Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
[TBL] [Abstract][Full Text] [Related]
18. Role of Equilibrative Nucleobase Transporter 1/SLC43A3 as a Ganciclovir Transporter in the Induction of Cytotoxic Effect of Ganciclovir in a Suicide Gene Therapy with Herpes Simplex Virus Thymidine Kinase.
Furukawa J; Inoue K; Ohta K; Yasujima T; Mimura Y; Yuasa H
J Pharmacol Exp Ther; 2017 Jan; 360(1):59-68. PubMed ID: 27807008
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S
Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
[TBL] [Abstract][Full Text] [Related]
20. Prodrug activation gene therapy and external beam irradiation in the treatment of prostate cancer.
Atkinson G; Hall SJ
Urology; 1999 Dec; 54(6):1098-104. PubMed ID: 10604717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
